Portfolio item number 1
Short description of portfolio item number 1
Short description of portfolio item number 1
Short description of portfolio item number 2 

Published in Frontiers in Psychiatry, 2025
This randomized pilot trial evaluates the safety, tolerability and clinical effects of hemp-derived cannabidiol in individuals with alcohol use disorder.
Recommended citation: Mueller RL, Hooper JF, Ellingson JM, Olsavsky AK, Rzasa-Lynn R, Bryan AD, Bidwell LC, Hutchison KE. (2025). A preliminary randomized trial of the safety, tolerability, and clinical effects of hemp-derived cannabidiol in alcohol use disorder. Front. Psychiatry. 16:1516351. doi: 10.3389/fpsyt.2025.1516351
Download Paper

Published in Frontiers in Psychology Sec. Consciousness Research, 2025
This study links the aesthetic quality of retrospective self-reported psychedelic experiences to measures of perceived insight and psychological outcomes.
Recommended citation: Hooper JF, Gyongyosi EL, Hutchison KE, Mueller RL. (2025). Aesthetic quality of psychedelic experience is linked to insight and psychological outcomes. Front. Psychol.. 16:1533055. doi: 10.3389/fpsyg.2025.1533055
Download Paper

Published in Neuropsychologia, 2025
This paper outlines neural mechanisms underlying the aesthetic experience during psychedelic states and calls for direct research.
Recommended citation: Hooper JF, Stoliker D, Wolfe K, Hutchison KE. (2025). Neuroaesthetics of the psychedelic state. Neuropsychologia. 109238. doi: 10.1016/j.neuropsychologia.2025.109238
Download Paper

Published in Frontiers in Psychology Sec. Consciousness Research, 2025
This study refines and validates the Psychedelic Aesthetic Experience Questionnaire, a tool designed to measure the aesthetic qualities of psychedelic experiences.
Recommended citation: Hooper JF, Ellingson JM, Hutchison KE. (2025). Preliminary Validation and Refinement of the Psychedelic Aesthetic Experience Questionnaire. Frontiers in Psychology. 16:1648968 doi: 10.3389/fpsyg.2025.1648968
Download Paper

Published in JAMA Psychiatry, 2025
This review synthesizes emerging data on psilocybin use trends, product variability, co-use with other substances, and adverse event reports. It highlights parallels with the cannabis legalization trajectory, showing that potency, product diversity, and unsupervised use are increasing while regulation and public education lag behind.
Recommended citation: Hutchison KE, Hooper JF, Karoly, HC. (2025). Psilocybin Outside the Clinic: Public Health Challenges of Increasing Publicity, Accessibility, and Use. JAMA Psychiatry. 2025 Nov 5. doi: 10.1001/jamapsychiatry.2025.3038.
Download Paper
Published:
This is a description of your talk, which is a markdown file that can be all markdown-ified like any other post. Yay markdown!
Published:
This is a description of your conference proceedings talk, note the different field in type. You can put anything in this field.
Undergraduate course, University 1, Department, 2014
This is a description of a teaching experience. You can use markdown like any other post.
Workshop, University 1, Department, 2015
This is a description of a teaching experience. You can use markdown like any other post.